ZoomMed: Full Revocation of Cease Trade Order
July 14 2023 - 9:12AM
ZoomMed Inc. (“
ZoomMed” or the
“
Corporation”) (NEX: ZMD) is pleased to announce
the full revocation as of today of the cease trade order which was
issued by the Autorité des marchés financiers and the Ontario
Securities Commission on October 5, 2018 pursuant to which all
trading in the securities of the Corporation, whether direct or
indirect, had to cease until the order is revoked (the
“
CTO”). The CTO was issued following the
Corporation’s failure to file, within the required time in
accordance with securities law, its annual audited financial
statements, annual management's discussion and analysis, and
certification of annual filings for its financial year ended May
31, 2018. This revocation follows the filing by ZoomMed of all
periodic continuous disclosure documents provided by the
legislation.
Pursuant to Policy Statement 11-207 Respecting
Failure-To-File Cease Trade Orders and Revocations in Multiple
Jurisdictions, ZoomMed will hold its annual and special meeting of
shareholders on July 25, 2023.
For further information on ZoomMed, please
contact Mr. Yves Marmet, President and Chief Executive Officer at
info@zoommed.com or visit our Web Site; www.zoommed.com or on SEDAR
at www.sedar.com.
Statements made in this press release that are
not historical facts are "forward-looking statements" and the
reader is cautioned that such statements are not guarantees of
future performance and that actual developments and results may
differ materially from those in such "forward-looking
statements".
Zoommed (TSXV:ZMD)
Historical Stock Chart
From Jul 2024 to Aug 2024
Zoommed (TSXV:ZMD)
Historical Stock Chart
From Aug 2023 to Aug 2024